HuGE Literature Finder
Records 1-28
[FREQUENCY OF POLYMORPHIC VARIANTS OF GSTT1 AND GSTM1 GENES IN PATIENTS WITH PULMONARY TUBERCULOSIS IN GEORGIAN POPULATION].
Georgian medical news 2019 Nov (296): 111-116. Jokhadze T, Buadze T, Gaiozishvili M, Kiria N, Khujadze I, Lezhava |
Relationship of anti-tuberculosis drug-induced liver injury and genetic polymorphisms in CYP2E1 AND GST.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2019 Nov . Santos Eliana Abreu, Gonçalves JoséCarlos Saraiva, Fleury Marcos K, Kritski Afrânio L, Oliveira Martha M, Velasque Luciane S, E Silva JoséRoberto Lapa, Estrela Ritade C Ássia |
Are genetic variations in glutathione S-transferases involved in anti-tuberculosis drug-induced liver injury? A meta-analysis.
Journal of clinical pharmacy and therapeutics 2019 Aug . Zhang Meng, Wu Shou-Quan, He Jian-Qi |
The association between BACH1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2018 12 66 217-221. Zhang Haiping, Qian Haisheng, Tao Bilin, Yang Miaomiao, Gong Jingye, Yi Honggang, Tang Shaow |
Meta-Analysis-Based Preliminary Exploration of the Connection between ATDILI and Schizophrenia by GSTM1/T1 Gene Polymorphisms.
PloS one 2015 10 (6): e0128643. Cai Lei, Cai Mei-Hong, Wang Mei-Yan, Xu Yi-Feng, Chen Wen-Zhong, Qin Shen-Ying, Wan Chun-Ling, He L |
Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity.
Tuberculosis (Edinburgh, Scotland) 2014 May 94 (3): 293-8. Singla Neha, Gupta Dheeraj, Birbian Niti, Singh Jagt |
N-acetyltransferase 2, cytochrome P4502E1 and glutathione S-transferase genotypes in antitubercular treatment-induced hepatotoxicity in North Indians.
Journal of clinical pharmacy and therapeutics 2014 Feb 39 (1): 91-6. Rana S V, Sharma S K, Ola R P, Kamboj J K, Malik A, Morya R K, Sinha S |
Genetic polymorphisms in metabolic enzymes and susceptibility to anti-tuberculosis drug-induced hepatic injury.
Genetics and molecular research : GMR 2014 13 (4): 9463-71. Feng F M, Guo M, Chen Y, Li S M, Zhang P, Sun S F, Zhang G |
Impact of glutathione S-transferase M1 and T1 on anti-tuberculosis drug-induced hepatotoxicity in Chinese pediatric patients.
PloS one 2014 9 (12): e115410. Liu Fang, Jiao An-xia, Wu Xi-rong, Zhao Wei, Yin Qing-qin, Qi Hui, Jiao Wei-wei, Xiao Jing, Sun Lin, Shen Chen, Tian Jian-ling, Shen Dan, Jacqz-Aigrain Evelyne, Shen A-do |
The incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1.
PloS one 2014 9 (1): e85905. Xiang Yang, Ma Long, Wu Weidong, Liu Wei, Li Yongguang, Zhu Xia, Wang Qian, Ma Jinfeng, Cao Mingqin, Wang Qian, Yao Xuemei, Yang Lei, Wubuli Atikaimu, Merle Corinne, Milligan Paul, Mao Ying, Gu Jiayi, Xin Xium |
GSTM1 and GSTT1 genetic polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity: an updated meta-analysis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2013 Feb . Li C, Long J, Hu X, Zhou Y |
GSTM1 and GSTT1 null polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2013 Jan 17 (1): 17-25. Tang N, Deng R, Wang Y, Lin M, Li H, Qiu Y, Hong M, Zhou |
Relationship of NAT2, CYP2E1 and GSTM1/GSTT1 polymorphisms with mild elevation of liver enzymes in Brazilian individuals under anti-tuberculosis drug therapy.
Clinica chimica acta; international journal of clinical chemistry 2013 Jan 415 215-9. Forestiero Francisco Jose, Cecon Leticia, Hirata Mario Hirouki, de Melo Fernando Fiuza, Cardoso Rosilene Fressatti, Cerda Alvaro, Hirata Rosario Dominguez Cres |
CYP2E1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity: a nested case-control study.
Journal of clinical pharmacy and therapeutics 2012 Oct 37 (5): 588-93. Tang S-W, Lv X-Z, Zhang Y, Wu S-S, Yang Z-R, Xia Y-Y, Tu D-H, Deng P-Y, Ma Y, Chen D-F, Zhan S |
Genetic Interaction between NAT2, GSTM1, GSTT1, CYP2E1, and Environmental Factors Is Associated with Adverse Reactions to Anti-Tuberculosis Drugs.
Molecular diagnosis & therapy 2012 Jul . Costa GN, Magno LA, Santana CV, Konstantinovas C, Saito ST, Machado M, Di Pietro G, Bastos-Rodrigues L, Miranda DM, De Marco LA, Romano-Silva MA, Rios-Santos F |
The roles of GSTM1 and GSTT1 null genotypes and other predictors in anti-tuberculosis drug-induced liver injury.
Journal of clinical pharmacy and therapeutics 2012 Jul . Monteiro TP, El-Jaick KB, Jeovanio-Silva AL, Brasil PE, Costa MJ, Rolla VC, de Castro L |
Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients.
Memórias do Instituto Oswaldo Cruz 2011 Sep 106 (6): 716-24. Teixeira Raquel Lima de Figueiredo, Morato Renata Gomes, Cabello Pedro Hernan, Muniz Ligia Mayumi Kitada, Moreira Adriana da Silva Rezende, Kritski Afrânio Lineu, Mello Fernanda Carvalho Queiroz, Suffys Philip Noel, Miranda Antonio Basilio de, Santos Adalberto Rezen |
GSTT1 and GSTM1 gene deletions are not associated with hepatotoxicity caused by antitubercular drugs.
Journal of clinical pharmacy and therapeutics 2010 Aug 35 (4): 465-70. Chatterjee S, Lyle N, Mandal A, Kundu |
Microarray-based detection of CYP1A1, CYP2C9, CYP2C19, CYP2D6, GSTT1, GSTM1, MTHFR, MTRR, NQO1, NAT2, HLA-DQA1, and AB0 allele frequencies in native Russians.
Genetic testing and molecular biomarkers 2010 Jun 14 (3): 329-42. Gra Olga, Mityaeva Olga, Berdichevets Iryna, Kozhekbaeva Zhanna, Fesenko Denis, Kurbatova Olga, Goldenkova-Pavlova Irina, Nasedkina Tatya |
Distribution of glutathione S-transferase T1 and M1 genes polymorphisms in North East Indians: a potential report.
Genetic testing and molecular biomarkers 2010 Apr 14 (2): 163-9. Thoudam Regina Devi, Yadav Dhirendra Singh, Mishra Ashwani Kumar, Kaushal Mishi, Ihsan Rakhshan, Chattopadhyay Indranil, Chauhan Pradeep Singh, Sarma Jagannath, Zomawia Eric, Verma Yogesh, Nandkumar A, Mahanta Jagadish, Phukan Rupkumar, Kapur Sujala, Saxena Suni |
[Analysis of genetic predisposition to pulmonary tuberculosis in native Russians].
Genetika 2010 Feb 46 (2): 262-71. Gra O A, Kozhekbaeva Zh M, Litvinov V |
[Genetic polymorphism of glutathione-S-transferase M1 and T1: a systematic review in Chinese population and a pilot study in smear-positive pulmonary tuberculosis cases of Jilin province].
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 2009 May 30 (5): 502-6. Li Xiao-ting, Yuan Yan-li, Xia Yin-yin, Yu Bao-zhu, Zhang Tie-juan, Liu Ou, Lv Xiao-zhen, Zhan Si-y |
Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2008 Sep 12 (9): 994-1002. Sun F, Chen Y, Xiang Y, Zhan |
Influence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population.
Liver international : official journal of the International Association for the Study of the Liver 2008 Jul 28 (6): 835-9. Leiro Virginia, Fernández-Villar Alberto, Valverde Diana, Constenla Lucía, Vázquez Rafael, Piñeiro Luis, González-Quintela Artu |
Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury.
Journal of hepatology 2007 Jul 47 (1): 128-34. Huang Yi-Shin, Su Wei-Juin, Huang Yi-Hsiang, Chen Chih-Yen, Chang Full-Young, Lin Han-Chieh, Lee Shou-Do |
Allele frequencies for glutathione S-transferase and N-acetyltransferase 2 differ in African population groups and may be associated with oesophageal cancer or tuberculosis incidence.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2003 Apr 41 (4): 600-5. Adams Craig H, Werely Cedric J, Victor Thomas C, Hoal Eileen G, Rossouw Gawie, van Helden Paul |
Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 'null' mutation.
Journal of gastroenterology and hepatology 2001 Sep 16 (9): 1033-7. Roy B, Chowdhury A, Kundu S, Santra A, Dey B, Chakraborty M, Majumder P |
Polymorphisms of NAT2, CYP2E1, GST, and HLA related to drug-induced liver injury in indonesian tuberculosis patients.
International journal of mycobacteriology 0 7 (4): 380-386. Perwitasari Dyah Aryani, Darmawan Endang, Mulyani Ully Adhi, Vlies Pieter Van Der, Alffenaar Jan-Willem C, Atthobar Jarir, Wilffert B |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 19, 2021
- Content source: